CSIMarket
 
Accuray Incorporated  (NASDAQ: ARAY)
 

Accuray Incorporated's Customers Performance

ARAY



 
ARAY's Source of Revenues During the corresponding time, Accuray Incorporated saw a revenue deteriorated by -21.14 % year on year, sequentially revenue fell by -3.24 %. While revenue at the Accuray Incorporated's corporate clients

List of ARAY Customers




for the same period Accuray Incorporated revnue deteriorated by -21.14 % year on year, sequentially revenue fell by -3.24 %.

List of ARAY Customers

Accuray Incorporated's Business Units
Product    171.14 % of total Revenue
Service    227.15 % of total Revenue
Americas    89.14 % of total Revenue
EIMEA    149.54 % of total Revenue
CN    67.52 % of total Revenue
JP    43.86 % of total Revenue
Asia Pacific    48.23 % of total Revenue






Accuray Incorporated's Comment on Sales, Marketing and Customers



The company provides products and services to healthcare providers, including clinicians such as radiation oncologists and neurosurgeons, in hospitals and cancer centers. Its product portfolio includes the CyberKnife robotic platform and helical systems such as Accuray Stellar, Radixact System, and Accuray Helix. These products are used to deliver precise, customized radiation treatments for patients with cancerous or benign tumors, as well as certain neurologic and endocrine disorders. The CyberKnife System supports radiosurgery applications involving the head, base of skull, and spine. The company targets multi-specialty use to assist customers in evaluating clinical, operational, and economic factors when making capital equipment decisions. It also participates in educational activities and collaborates with clinicians and researchers to support clinical development and product innovation. Customers and markets mentioned in company filings include the American Cancer Society and the World Health Organization.





Accuray Incorporated’s Comment on Sales, Marketing and Customers


The company provides products and services to healthcare providers, including clinicians such as radiation oncologists and neurosurgeons, in hospitals and cancer centers. Its product portfolio includes the CyberKnife robotic platform and helical systems such as Accuray Stellar, Radixact System, and Accuray Helix. These products are used to deliver precise, customized radiation treatments for patients with cancerous or benign tumors, as well as certain neurologic and endocrine disorders. The CyberKnife System supports radiosurgery applications involving the head, base of skull, and spine. The company targets multi-specialty use to assist customers in evaluating clinical, operational, and economic factors when making capital equipment decisions. It also participates in educational activities and collaborates with clinicians and researchers to support clinical development and product innovation. Customers and markets mentioned in company filings include the American Cancer Society and the World Health Organization.








ARAY's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Accuray Incorporated 30.52 427.89 -46.13 809
SUBTOTAL 0.00 0.00 0.00 -

Sources: Accuray Incorporated’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Accuray Incorporated’s corporate clients.
For your research, we’ve provided 9 tables on Accuray Incorporated corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.